000 02253 a2200601 4500
005 20250513174415.0
264 0 _c19990527
008 199905s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0702324
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVillalón, C M
245 0 0 _aCanine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cFeb 1999
300 _a585-94 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic alpha-1 Receptor Antagonists
650 0 4 _aAdrenergic alpha-2 Receptor Agonists
650 0 4 _aAdrenergic alpha-2 Receptor Antagonists
650 0 4 _aAdrenergic alpha-Agonists
_xpharmacology
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBlood Flow Velocity
_xdrug effects
650 0 4 _aCarotid Arteries
_xdrug effects
650 0 4 _aClonidine
_xpharmacology
650 0 4 _aDihydroergotamine
_xpharmacology
650 0 4 _aDogs
650 0 4 _aErgotamine
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aMale
650 0 4 _aMethysergide
_xpharmacology
650 0 4 _aOxadiazoles
_xpharmacology
650 0 4 _aPhenylephrine
_xpharmacology
650 0 4 _aPiperazines
_xpharmacology
650 0 4 _aPrazosin
_xpharmacology
650 0 4 _aReceptor, Serotonin, 5-HT1B
650 0 4 _aReceptor, Serotonin, 5-HT1D
650 0 4 _aReceptors, Adrenergic, alpha-2
_xphysiology
650 0 4 _aReceptors, Serotonin
_xdrug effects
650 0 4 _aSerotonin Antagonists
_xpharmacology
650 0 4 _aSumatriptan
_xpharmacology
650 0 4 _aVasoconstriction
_xdrug effects
650 0 4 _aVasoconstrictor Agents
_xpharmacology
650 0 4 _aYohimbine
_xpharmacology
700 1 _aDe Vries, P
700 1 _aRabelo, G
700 1 _aCenturión, D
700 1 _aSánchez-López, A
700 1 _aSaxena, P
773 0 _tBritish journal of pharmacology
_gvol. 126
_gno. 3
_gp. 585-94
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0702324
_zAvailable from publisher's website
999 _c10148443
_d10148443